New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - meropenem trihydrate 570mg equivalent to meropenem 500mg;   - powder for injection - 500 mg - active: meropenem trihydrate 570mg equivalent to meropenem 500mg   excipient: sodium carbonate - meropenem-aft is indicated for treatment, in adults and children, of the following infections caused by multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: · lower respiratory tract infections · urinary tract infections, including complicated infections · intra-abdominal infections · gynaecological infections, including postpartum infections · skin and skin structure infections · meningitis · septicaemia · empiric treatment, including initial monotherapy, for presumed bacterial infections in host-compromised, neutropenic patients because of its broad spectrum of bactericidal activity against gram positive and gram-negative aerobic and anaerobic bacteria, meropenem is effective for the treatment of polymicrobial infections.

United States - English - NLM (National Library of Medicine)

savior lifetec corporation - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem 1 g in 30 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of meropenem for injection and other antibacterial drugs, meropenem for injection should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. meropenem for injection is useful as presumptive therapy in the indicated condition (e.g. intra-abdominal infections) prior to the identification of the causative organisms because of its broad spectrum of bactericidal activity. for information regarding use in pediatric patients see indications and usage (1.1), (1.2) or (1.3) ; dosage and administration (2.3) , adverse reactions (6.1) , and clinical pharmacology (12.3) . meropenem for injection is indicated as a

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - powder for solution for inj/inf - meropenem as trihydrate 1000 mg/vial - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - meropenem as trihydrate - powder for solution for inj/inf - meropenem as trihydrate 500 mg/vial - meropenem - meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis -septicemia. meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Canada - English - Health Canada

jamp pharma corporation - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g

Canada - English - Health Canada

jamp pharma corporation - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - meropenem trihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - meropenem trihydrate -

Canada - English - Health Canada

sterimax inc - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g - carbapenems

Canada - English - Health Canada

sterimax inc - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg - carbapenems